Skip to main content
Screener/Healthcare/Biotechnology

NVAX — Novavax, Inc.

NASDAQ
$9.15+0.14 (+1.56%)
Small CapUnder $10HealthcareFastest GrowingHigh BetaLow P/EUndervalued
$6.13
$11.97
$8.81
$9.59
EPS (TTM)$2.39
P/E Ratio3.83
Dividend Yield—
Market Cap$1.50B
Volume3.17M
Prev Close$9.00
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$147.1M$17.5M$0.1182.9%11.9%
Q3 '25$70.4M-$202.4M$-1.2569.5%-287.3%
Q2 '25$239.2M$106.5M$0.6094.1%44.5%
Q1 '25$666.7M$518.6M$2.9397.9%77.8%
Q4 '24$88.3M-$81.0M$-0.5158.5%-91.8%
Q3 '24$84.5M-$121.3M$-0.7628.3%-143.5%
Q2 '24$415.5M$162.4M$0.9988.9%39.1%
Q1 '24$93.9M-$147.6M$-1.0548.0%-157.2%
Get Your Daily Market Recap